PATENT CLAIM ANALYSIS

Application Number: 16514835
Application Type: Utility
Filing Date: 2019-07
Publication Date: 2019-11
Patent Classification: ["514", "252030"]

Abstract:
The present invention aims to provide a compound having a TrkA inhibitory action, a pharmaceutically acceptable salt thereof, or a solvate thereof, a pharmaceutical composition containing the same as an active ingredient, and a preventive and/or therapeutic agent for medicinal use, in particular for a disease in which TrkA in involved (pain, cancers, inflammation/inflammatory diseases, allergic diseases, skin diseases, neurodegenerative diseases, infectious diseases, Sjogren's syndrome, endometriosis, renal diseases, osteoporosis, and the like). Specifically, the present invention provides a compound or an optical isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or the like, the compound

Claim (Index 15):
The compound of  claim 1  wherein the R 4a  of the ring A is a hydrogen atom or a C 1-6  alkyl group.

Metadata:
- Claim Count in Document: 116.0
- Percentile: 100.0
- Lexical Diversity: 1.93651
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16138369', '11988659', '13008456', '14477672', '14442609']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7757721329424226
- 35 USC 102 Novelty (BERT): 0.5678939560645899
- Combined Prediction Score: 0.7549843152546394
- Mean Citation Score: 353.857042
- Max Citation Score: 448.06613
- Similarity Product: 350.68531013347985

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test